S1‐Leitlinie: Kaposi‐Sarkom

Stefan Eßer(Essen University Hospital), Stephan Grabbe(Goethe University Frankfurt), Mark Oette, Thomas F. Schulz(Medizinische Hochschule Hannover), Anja Potthoff(Ruhr University Bochum), Helmut Schöfer(Goethe University Frankfurt), Franz Mosthaf, Doris Helbig(University Hospital Cologne), Selma Ugurel(Klinikum Bielefeld), Jürgen C. Becker(Düsseldorf University Hospital), Norbert H. Brockmeyer(Deutsches Bergbau-Museum Bochum), Mirjana Ziemer(University Medical Center), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Ulrike Leiter(University of Tübingen), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), E. Bierhoff, Johannes Claßen(St. Vincentius-Kliniken), Judith Sirokay(University Hospital Bonn)
JDDG Journal der Deutschen Dermatologischen Gesellschaft
June 1, 2022
10.1111/ddg.14788_g
Cited by 5

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Germline mutations in BAP1 predispose to melanocytic tumors
|Nature Genetics|2011|724
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
|The Lancet Oncology|2016|704